Cases
Cases
Updated Oct 22, 12:45 AM ET
Petition filed
Plan confirmed
Humanigen is in post-confirmation liquidation through the HGEN Liquidating Trust, which reported no plan payments for April–June 2026 in its October 14 report Dkt. 401. The next material work is claims reconciliation and litigation review, with claims objections permitted through January 4, 2027 under the claims-objection order Dkt. 392 and removal of related civil actions permitted through March 29, 2027 under the October 13 order Dkt. 398.
Search available documents for this case. Full docket access requires Pro.
Open case researchHumanigen Sells Assets to Taran Therapeutics After FDA Denial, Backed by $2M Insider Loan ·
Case facts and filing dates come from court records.
Updated Oct 22, 12:45 AM ET
Petition filed
Plan confirmed
Humanigen is in post-confirmation liquidation through the HGEN Liquidating Trust, which reported no plan payments for April–June 2026 in its October 14 report Dkt. 401. The next material work is claims reconciliation and litigation review, with claims objections permitted through January 4, 2027 under the claims-objection order Dkt. 392 and removal of related civil actions permitted through March 29, 2027 under the October 13 order Dkt. 398.
Search available documents for this case. Full docket access requires Pro.
Open case researchHumanigen Sells Assets to Taran Therapeutics After FDA Denial, Backed by $2M Insider Loan ·
Case facts and filing dates come from court records.